Paper7614902
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop.
Richman DD and 1 other. Drugs, 1995. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. Papers, record 7614902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7614902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| Zidovudine | Major topic |
| CD4 Lymphocyte Count | |
| Clinical Trials as Topic | |
| Humans | |
| Survival Analysis | |
| Time Factors | |
| Virus Replication |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI27670 | NIAID NIH HHS | United States | U01AI027670 | PubMed and NIH | NIH RePORTER |
| AI29164 | NIAID NIH HHS | United States | R01AI029164 | PubMed and NIH | NIH RePORTER |
| AI30457 | NIAID NIH HHS | United States | U01AI030457 | PubMed and NIH | NIH RePORTER |
| R37AI029164 | NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1969115 | Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. | N Engl J Med | 1990 | https://conductscience.org/library/papers/1969115 | PubMed |
| 2 | 1970466 | The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. | Ann Intern Med | 1990 | https://conductscience.org/library/papers/1970466 | PubMed |
| 3 | 7905722 | Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. | Ann Intern Med | 1994 | https://conductscience.org/library/papers/7905722 | PubMed |
| 4 | 1353607 | A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1353607 | PubMed |
| 5 | 8100611 | Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8100611 | PubMed |
| 6 | 2191113 | Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. | J Acquir Immune Defic Syndr (1988) | 1990 | https://conductscience.org/library/papers/2191113 | PubMed |
| 7 | 7816094 | Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. | Nature | 1995 | https://conductscience.org/library/papers/7816094 | PubMed |
| 8 | 8096089 | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. | Science | 1993 | https://conductscience.org/library/papers/8096089 | PubMed |
| 9 | 8455722 | HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. | Nature | 1993 | https://conductscience.org/library/papers/8455722 | PubMed |
| 10 | 3124680 | Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3124680 | PubMed |
| 11 | 8093363 | 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8093363 | PubMed |
| 12 | 2510843 | Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. | BMJ | 1989 | https://conductscience.org/library/papers/2510843 | PubMed |
| 13 | 2904016 | Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. | Lancet | 1988 | https://conductscience.org/library/papers/2904016 | PubMed |
| 14 | 8093551 | The immunopathogenesis of human immunodeficiency virus infection. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8093551 | PubMed |
| 15 | 2891981 | Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). | Lancet | 1988 | https://conductscience.org/library/papers/2891981 | PubMed |
| 16 | 7901434 | Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. | JAMA | 1993 | https://conductscience.org/library/papers/7901434 | PubMed |
| 17 | 3044087 | Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. | Am J Med | 1988 | https://conductscience.org/library/papers/3044087 | PubMed |
| 18 | 2467383 | HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. | Science | 1989 | https://conductscience.org/library/papers/2467383 | PubMed |
| 19 | 8096373 | CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8096373 | PubMed |
| 20 | 3299090 | The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3299090 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7614902
GET https://conductscience.org/api/papers/v1/7614902/references?page=2